Recording of the webinar "Disease and treatment specificities for young myeloma patients" organised by the MPE’s European Young Myeloma Patients Group. The webinar was given by Prof. Dr. Michel Delforge, Clinical Head of Haematology at the University Hospital UZ Leuven, Belgium, and Professor of Medicine at the KU Leuven, on 9 July 2024.
-
MPE webinar | Disease and treatment specificities for young myeloma patients
-
MPE Webinar | EHA 2024 myeloma highlights
-
MPE and ALAN webinar | Patient and clinician involvement in the EU HTA regulation
-
MPE/ALAN Webinar | EU HTA
-
MPE webinar | AL amyloidosis treatment updates and patient experiences
-
Webinar | Basics of medicines pricing in Europe
-
European Young Myeloma Patients Group launch event
-
MPE Webinar ASH 2023 myeloma and AL amyloidosis highlights
-
Webinar | EHA 2023 myeloma and AL amyloidosis highlights
-
Webinar The importance and challenges of measuring quality of life in myeloma clinical trials
-
Webinar | Patient and haematologist perspectives on Minimal Residual Disease testing in myeloma
-
Webinar | Doctor and patients' perspective on myeloma CAR-T